Skip to main content

Melissa Weiss, Associate Editor

Melissa Weiss, Associate Editor
Findings from two randomized, vehicle-controlled trials showed a nonsteroidal topical treatment effectively improved psoriasis, including in difficult-to-treat areas. Mark Lebwohl, MD, discussed the implications of these findings in an interview with The Dermatologist.
Melissa Weiss, Associate Editor
A recent systematic review analyzed the role of multidisciplinary clinics for the treatment of patients with psychocutaneous diseases, including delusional infestation. Corresponding author Mohammad Jafferany, MD, discussed these findings further in an interview with The Dermatologist.
Melissa Weiss, Associate Editor
Tuberous sclerosis complex (TSC) is a rare, multiorgan, genetic disease with many cutaneous findings. In an interview with The Dermatologist, Elizabeth Thiele, MD, PhD, director of the TSC Center at Harvard Medical School, discusses common cutaneous symptoms of this disease.
Melissa Weiss, Associate Editor
A recent study found clinical trials that assessed the safety and efficacy of atopic dermatitis treatment rarely included older adults, with some even excluding patients younger than 60 years. Corresponding author Aaron Drucker, MD, discussed these findings and the importance of including older adults in trials for clinical practice.
Melissa Weiss, Associate Editor
Jesse Veenstra, MD, PhD, discussed the findings from the recent Henry Ford Health System study on the risk of COVID-19 infection and severe outcomes among patients with immune-mediated inflammatory diseases treated with immunosuppressive therapies.
Melissa Weiss, Associate Editor
A recent study highlighted several common patient-reported symptoms of hidradenitis suppurativa flares, including pain and drainage. In an interview with The Dermatologist, study authors Jennifer M. Fernandez, RD, and Vivian Shi, MD, discussed these findings and their implications for clinical practice.
Melissa Weiss, Associate Editor
The following is an excerpt from Pearls in Psoriasis with Dr Lawrence Green, featuring Dr April Armstrong and her study on patient mental health and satisfaction with their physicians.
Melissa Weiss, Associate Editor
A new large-scale study is underway to assess the impact of systemic therapies on COVID-19 among patients with atopic dermatitis and psoriasis. Dr Emma Guttman discusses the goals of the study and how it could help shape COVID-19 treatment among patients with inflammatory skin diseases.
Melissa Weiss, Associate Editor
Findings from a recent study showed tape strips may be a minimally invasive alternative to skin biopsies. Emma Guttman, MD, PhD, discussed these findings and their implications for clinical trials and practice.
Melissa Weiss, Associate Editor
When it comes to dermatology fellowship programs, accessible information may be the difference between candidates applying or not applying to their perfect “match.” Chapman Wei, BS, and Adam Friedman, MD, FAAD, discuss the importance of dermatology programs updating their websites to include more thorough descriptions and information regarding their programs, especially in the context of the current pandemic.
Back to Top